Decoding Multiple Sclerosis Genetics: A Dual-Function Variant Linking circRNA Regulation and Alternative Splicing
Multiple sclerosis (MS) is a complex autoimmune disorder characterized by chronic inflammation, demyelination, and neurodegeneration within the central nervous system. While genome-wide association studies (GWAS) have identified over 200 susceptibility loci, the mechanistic interpretation of these variants remains incomplete. Traditionally, research has focused on protein-coding genes; however, emerging evidence highlights the regulatory significance of non-coding RNAs, including circular RNAs (circRNAs), in immune-mediated diseases. The present study introduces a novel dimension by investigating how genetic variants influence circRNA expression and alternative splicing, thereby refining our understanding of MS pathogenesis .
CircRNAs and Genetic Regulation: The Role of circ-eQTLs
Circular RNAs are covalently closed RNA molecules generated through back-splicing events. Their stability and regulatory capacity—such as acting as microRNA sponges or transcriptional modulators—make them particularly relevant in complex diseases. This study hypothesized that genetic variants may act as circRNA expression quantitative trait loci (circ-eQTLs), analogous to classical eQTLs but specific to circular transcripts. Through integration of RNA-seq and genome-wide genotyping data, the authors identified 42,077 significant cis circ-eQTLs, indicating widespread genetic control over circRNA expression in leukocytes . This scale of regulatory interaction underscores the importance of incorporating non-coding RNA layers into genetic association studies.
Study Design and Analytical Framework
The investigation employed a multi-stage design combining discovery, validation, and association cohorts. Initially, circRNA expression from RNA-seq (22,835 detected circRNAs) was correlated with ~4.8 million imputed variants using linear regression models adjusted for sex and disease status. As illustrated in the workflow diagram on page 18, candidate circ-eQTLs were filtered by false discovery rate (FDR < 0.05) and minor allele frequency thresholds, followed by intersection with known MS-associated loci and splicing QTLs (sQTLs). Validation was conducted using RT-qPCR in independent cohorts, while a large-scale case-control study (over 6,000 individuals) assessed disease association . This integrative pipeline exemplifies a robust systems-genomics approach.
Identification of a Dual-Function Variant on Chromosome 17
Among the prioritized candidates, the single nucleotide polymorphism rs7214410 emerged as a key regulatory variant. It significantly modulates the expression of the circRNA hsa_circ_0106983, with individuals carrying the alternative allele exhibiting reduced expression levels. Notably, another SNP in the same region (rs11079784), previously identified as a GWAS lead variant, also influenced the same circRNA but with weaker disease association. The comparative statistical analysis (Table 2 and 3, page 16) demonstrates that rs7214410 shows a stronger association with MS risk (OR = 1.17), suggesting it may represent the true causal variant within this locus .
Coupling circRNA Expression with Alternative Splicing
A central finding of this study is the dual functionality of rs7214410: in addition to acting as a circ-eQTL, it also functions as an sQTL affecting the EFCAB13 gene. Experimental validation using gel electrophoresis revealed genotype-dependent exon skipping, particularly the loss of exons 9 and 10 in individuals carrying the G allele. This was accompanied by altered isoform distribution, with increased abundance of truncated transcripts. Importantly, while splicing patterns were significantly affected, total linear gene expression remained unchanged. This decoupling suggests that regulatory variants may exert their biological effects primarily through transcript isoform diversity rather than overall gene expression levels .
Functional Implications and Mechanistic Hypotheses
The convergence of circRNA regulation and alternative splicing at a single genomic locus provides compelling evidence for coordinated transcriptomic control. Since circRNA biogenesis itself is a form of alternative splicing, the observed effects may reflect competition between linear and circular RNA processing pathways. The authors propose that the G allele of rs7214410 may bias the splicing machinery toward exon skipping, thereby reducing circRNA formation. Given that EFCAB13 encodes a calcium-binding protein with potential roles in neuronal signaling, these transcriptomic alterations could influence immune-neural interactions central to MS pathology. However, the precise functional role of hsa_circ_0106983 remains to be elucidated.
Conclusions and Future Directions
This study provides a comprehensive demonstration that genetic variants can simultaneously regulate circRNA expression and alternative splicing, revealing a previously underappreciated layer of genetic regulation in multiple sclerosis. By identifying rs7214410 as a dual-function variant, the work refines a known MS susceptibility locus and highlights the importance of non-coding RNA biology in disease mechanisms. Future research should focus on functional characterization of circRNAs, cell-type-specific effects, and integration with epigenomic and proteomic data. Ultimately, such insights may contribute to the development of novel biomarkers or therapeutic targets centered on RNA regulatory networks .
Disclaimer: This blog post is based on the provided research article and is intended for informational purposes only. It is not intended to provide medical advice. Please consult with a healthcare professional for any health concerns.
References:
Iniguez, S. G., Iparraguirre, L., Andres-Leon, E., Crespillo, H., Romarate, L., Castillo-Trivino, T., ... & Munoz-Culla, M. (2026). A dual-function variant on chromosome 17 regulates circRNA expression and splicing in multiple sclerosis. bioRxiv, 2026-03.
